<<

. 3
( 3 .)



26. Sgadari C, Barillari G, Toschi E, et al. HIV protease inhibitors are potent anti-angiogenic
molecules and promote regression of Kaposi sarcoma. Nat Med 2002, 8:225-32.
http://amedeo.com/lit.php?id=11875492
27. Ramirez-Amador V, Esquivel-Pedraza L, Lozada-Nur F, et al. Intralesional vinblastine
vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi's sarcoma. A double
blind, randomized clinical trial. Oral Oncol 2002, 38:460-7.
http://amedeo.com/lit.php?id=12110340
28. Rosenthal E, Poizot-Martin I, Saint-Marc T, Spano JP, Cacoub P; DNX Study Group.
Phase IV study of liposomal daunorubicin (DaunoXome) in AIDS-related Kaposi
sarcoma. Am J Clin Oncol. 2002,25:57-9.
29. Schwartz RA (2004) Kaposi's sarcoma: an update. J Surg Oncol 87:146-51.
30. Tappero JW, Conant MA, Wolfe SF, et al. Kaposi's sarcoma: epidemiology,
pathogenesis, histology, clinical spectrum, staging criteria and therapy. J Am Acad
Dermatol 1993, 28: 371-95. http://amedeo.com/lit.php?id=8445054
31. Thoma-Greber E, Sander CA, Messer G, Rocken M. Pegyliertes Interferon-?2b: Neue
Therapie bei klassischem Kaposi-Sarkom. Diaklinik Munchner Fortbildungswoche fur
Dermatologen 2002, 52-4.
32. Triantos D, Horefti E, Paximadi E, Kyriakopoulou Z, Karakassiliotis G, Papanastasiou K,
Lelekis M, Panos G, Donta-Bakoyianni C, Rapidis A, Markoulatos P. Presence of human
herpes virus-8 in saliva and non-lesional oral mucosa in HIV-infected and oncologic
immunocompromised patients. Oral Microbiol Immunol. 2004,19:201-4.
33. Tulpule A, Groopman J, Saville MW, et al. Multicenter trial of low-dose paclitaxel in
patients with advanced AIDS-related Kaposi sarcoma. Cancer 2002, 95:147-54.
http://amedeo.com/lit.php?id=12115328
34. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi sarcoma
associated herpesvirus in peripheral blood of HIV-infected individuals and progression to
Kaposi’s sarcoma. Lancet 1995, 346: 799-802. http://amedeo.com/lit.php?id=7674745
35. Yarchoan R. Therapy for Kaposi’s sarcoma: recent advances and experimental
approaches. J Acquir Immune Defic Syndr 1999, 21 Suppl 1: S66-73.
http://amedeo.com/lit.php?id=10430221

<<

. 3
( 3 .)